Hi both
This is the statement from BCC on this subject for your interest:
Commenting on a major breast cancer study into bisphosphonates, led by researchers at Oxford and the University of Sheffield, Samia al Qadhi, Chief Exectuive at Breast Cancer Care, adds: “This study on bisphosphonates is good news for women with breast cancer. Treatments such as aromatase inhibitors can cause bones to become frail and sometimes fracture. Bisphosphonates can strengthen the bones, which will help women tolerate and complete aromatase inhibitor treatments. “A key finding from this study is that bisphosphonates can also lower the risk of the breast cancer spreading to the bones - the most common area breast cancer spreads to - as well as reducing the risk of dying from breast cancer in post-menopausal women. We know how terrified people are that their cancer will spread so any drug that can lower this risk is very welcome. “Bisphosphonates do have side effects as well. They can cause low levels of calcium in the blood and flu like symptoms. They can also irritate the gullet and on rare occasions damage the jaw bone.”
Best wishes
Lucy BCC
... View more